Literature DB >> 10354976

Optimizing atrial defibrillation.

A Prakash, S Saksena.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10354976     DOI： 10.1023/a:1009823523425

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  9 in total

1.  Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation.

Authors:  I Giorgberidze; S Saksena; L Mongeon; R Mehra; R B Krol; A N Munsif; P Mathew
Journal:  J Interv Card Electrophysiol       Date:  1997-09       Impact factor: 1.900

2.  Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation.

Authors:  M Santini; C Pandozi; G Altamura; G Gentilucci; M Villani; M C Scianaro; A Castro; F Ammirati; B Magris
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

3.  Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.

Authors:  S Lévy; P Ricard; C P Lau; N S Lok; A J Camm; F D Murgatroyd; L J Jordaens; L J Kappenberger; P Brugada; K L Ripley
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

4.  Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.

Authors:  N S Lok; C P Lau; H F Tse; G M Ayers
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

5.  A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia.

Authors:  J M Ciccone; S Saksena; Y Shah; D Pantopoulos
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

6.  Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention.

Authors:  P Delfaut; S Saksena; A Prakash; R B Krol
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

7.  Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.

Authors:  F D Murgatroyd; A K Slade; S M Sopher; E Rowland; D E Ward; A J Camm
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

8.  Atrioverter: an implantable device for the treatment of atrial fibrillation.

Authors:  H J Wellens; C P Lau; B Lüderitz; M Akhtar; A L Waldo; A J Camm; C Timmermans; H F Tse; W Jung; L Jordaens; G Ayers
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

9.  Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations.

Authors:  S Saksena; A Prakash; L Mangeon; S Varanasi; T Kolettis; P Mathew; P De Groot; R Mehra; R B Krol
Journal:  Am J Cardiol       Date:  1995-11-01       Impact factor: 2.778
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.